Active Pharmaceutical Ingredients in Italy


November 1, 2011
42 Pages - SKU: CGSP3894949
License type:
Countries covered: Italy

This report supplies information on the Active Pharmaceutical Ingredients Italian market and its competitors: market trends, SWOT and key success factors analysis, major companies performance indicators (total turnover, sector specific turnover, market shares and export quotas), business prospects and trends.

Scope

This report provides an overview of basic pharmaceutical products, also known as APIs (Active Pharmaceutical Ingredients).
  • Product technology: active pharmaceutical ingredients are produced by chemical synthesis, semi-synthesis, fermentation or extraction.
  • Use: APIs are used in the production of pharmaceutical specialities.
  • Client groups: pharmaceutical companies producing specialities under their own brand names or producing equivalent (generic) pharmaceuticals.
The analysis excludes the following product categories: raw materials and intermediate materials; active ingredients for captive use by pharmaceutical companies in the speciality medicines segment; active ingredients for cosmetic or dietary use; pharmaceutical substances used as raw material in the formulation of specialities but without specific therapeutic or preventive activity; substances used as contrast medium; medicinal specialities; animal organ extracts leading directly to preventive specialities, such as serums and vaccines; plant extracts destined for other segments, such as dietary or cosmetic products.

Segments

The report analyses the following business lines:
  • Antibiotics (cephalosporin, penicillin and others);
  • Synthetic ingredients (non-antibiotics);
  • Steroids (derived from hormonal substances);
  • Organomedicines (extracts from organs or hormones of animal origin);
  • Phytomedicines: (plant extracts).
Methodology

Databank’s methodology for Competitors reports begins with a careful screening to identify the main organisations that are representative of a given sector. Several one-to-one interviews are then conducted with the selected organisations. Questionnaires are sent to all the leading companies on an annual basis. The information collected is then verified by an expert in the particular sector using a system of counterchecks to guarantee that the information is entirely reliable and consistent. The process is then completed using Cerved Group’s proprietary information about Italian enterprises. All Competitors reports also include details concerning the strategies and performances of the leading companies in each sector.

Wherever no specific source is indicated, the information published in these reports can be assumed to have been taken from Cerved Group’s proprietary information bank. Coverage of any sector in Competitors products may be used in company presentations or in training courses on the subject.



More Italy Manufacturing, Packaging & Detailing reports

Italy Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: The ongoing hospital debt situation, in addition to the Italian government's focus on dereimbursement,will offset any benefits of the recently passed legislation that ...
Italy Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: The sharp drop in public pharmaceutical expenditure in Italy in the first four months of 2012serves as a warning for the continuation of ...
Italy Pharmaceutical Market Overview – Challenging outlook due to austerity and falling birth rate by Datamonitor
IntroductionHigh national debt and a falling birth rate create a poor economic outlook and challenging market environment for pharma companies in Italy. Generic penetration is ...
Italy: Market Access Tracker by Decision Resources
The Italian pharmaceutical market is the third largest in Europe and the eighth largest in the world, with ex-manufacturer sales in retail pharmacies ...
See all reports like this >>

More Italy reports

D&B Country RiskLine Report: Italy by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Italy by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Italy: Country Profile by MarketLine
INTRODUCTIONThis report provides a detailed analysis of Italy, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 Italy Industry & Market Outlook report by Barnes Reports
The 2007 Italy Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Italy and 500+ minor industries ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!